Time course of antibody response to recombinant Aspergillus fumigatus antigens in cystic fibrosis with and without ABPA
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
We determined follow‐up levels of specific serum IgE to the recombinant Aspergillus fumigatus (A. fumigatus) allergens rAsp f 1, 3, 4 and 6 in patients suffering from cystic fibrosis (CF) with and without allergic bronchopulmonary aspergillosis (ABPA). Over a 32‐month period follow‐up data of 74 patients were collected. According to serology, 11 CF patients were not sensitized (CF controls), 40 were sensitized to A. fumigatus (Asp. f‐sens.) and 23 patients fulfilled the serologic criteria for ABPA. Of these 23 ABPA patients 11 expressed the full clinical ABPA picture (classicABPA) and 12 failed to show sufficient relevant clinical signs (seroABPA), despite positive serology. The 23 ABPA patients had 16–18 times higher serum levels of specific IgE to rAsp f 4 and/or rAsp f 6 than those of Asp. f‐sens. patients (rAsp f 4: 31.3 ± 45 EU/ml vs. 1.9 ± 2.2 EU/ml and rAsp f 6: 39.0 ± 44.3 EU/ml vs 2.1 ± 1.7 EU/ml). The combination of increased total serum IgE (>1000 IU/l) and increased specific IgE to rAsp f 4 and/or rAsp f 6 allowed to diagnose classicABPA with 100% specificity and 64% sensitivity and with a high predicted positive (100%) and a high predicted negative (94%) value. During a combined treatment (seven patients) with oral corticosteroid and itraconazole, itraconazole alone (two patients) or neither oral corticosteroid nor itraconazole therapy (two patients) total serum IgE and specific IgE to rAsp f 4 and/or rAsp f 6 did decrease but did not normalize. Over the observation period, lung function remained unchanged, independent of whether oral steroids and/or concomitant itraconazole were either given or not given. In the follow‐up of CF patients with ABPA under therapy the determination of total or specific IgE serum levels were of limited value to guide therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stevens, D. A., Moss, R. B., Kurup, V. P., Knutsen, A. P., Greenberger, P., Judson, M. A., Denning, D. W., Crameri, R., Brody, A. S., Light, M., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/376525 · Cited by 790 · cited 2×
“The recent Consensus Report (29) still reflects the ongoing uncertainty in diagnosing and treating ABPA in CF patients.”
BackgroundSelf-citation
Cited by
A WAO - ARIA - GA²LEN consensus document on molecular-based allergy diagnostics
Canonica, G. W., Ansotegui, I. J., Pawankar, R., Schmid-Grendelmeier, P., van Hage, M., Baena-Cagnani, C. E., Melioli, G., Nunes, C., Passalacqua, G., Rosenwasser, L., et al. (2013) · World Allergy Organization Journal · doi:10.1186/1939-4551-6-17 · Cited by 432
“In hypersensitivity reactions to Aspergillus fumigatus, the presence of IgE antibody reactivity to Asp f 2, 4, and 6 may suggest allergic bronchopulmonary aspergillosis (ABPA) [72], whereas sensitization to Asp f 1 and/or Asp f 3 may be more indicative of allergic asthma [73].”
BackgroundMolecular diagnosis in allergy
Sastre, J. (2010) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2010.03585.x · Cited by 235
Effect of Allergic Bronchopulmonary Aspergillosis on Lung Function in Children with Cystic Fibrosis
Kraemer, R., Deloséa, N., Ballinari, P., Gallati, S., & Crameri, R. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200603-423oc · Cited by 179
“The diagnosis of ABPA in patients with CF is complicated by a number of characteristics shared by the two diseases, including pulmonary infiltrates, A. fumigatus sensitization, elevated specific IgE and IgG antibodies to A. fumigatus extract, as well as centrally located bronchiectasis (1, 6). Therefore, serologic fin…”
BackgroundResultInfluentialSelf-citationPostigo, I., Gutiérrez-Rodríguez, A., Fernández, J., Guisantes, J. A., Suñén, E., & Martínez, J. (2011) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2010.03671.x · Cited by 51
(2013) · PubMed · Cited by 20
Metadata
- Authors
- Casaulta, C., Flückiger, S., Crameri, R., Blaser, K., & Schoeni, M. H.
- Venue
- Pediatric Allergy and Immunology
- Publisher
- Wiley
- Published
- 2005-04-25
- Volume
- 16
- Issue
- 3
- Pages
- 217-225
- ISSN
- 0905-6157 (ISSN-L)
- 1399-3038
- OpenAlex
- W1978792476
- Cited by
- 57
- References
- 1
- FWCI
- 2.47
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Time course of antibody response to recombinant Aspergillus fumigatus antigens in cystic fibrosis with and without ABPA. https://app.cochat.ai/papers/10.1111/j.1399-3038.2005.00262.x
- The paper
- Casaulta, C., Flückiger, S., Crameri, R., Blaser, K., & Schoeni, M. H. (2005). Time course of antibody response to recombinant Aspergillus fumigatus antigens in cystic fibrosis with and without ABPA. Pediatric Allergy and Immunology. https://doi.org/10.1111/j.1399-3038.2005.00262.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.